CA
NZ
UK
AU
IND
US
…
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Dr. Martens plc designs, manufactures and sells branded footwear, accessories and apparel through wholesale partners, company-owned stores and direct-to-consumer e-commerce globally. Major long-term growth drivers include expansion in North America and Asia, growth of online sales and limited-edition collaborations that could support margin improvement. The company may appeal to investors for its iconic brand, diversified channel mix and potential pricing power.
Key risks include sensitivity to consumer discretionary cycles and fashion trends, competitive pressure from other footwear brands, supply-chain and manufacturing disruptions along with raw-material and foreign-exchange exposure that could weigh on margins and growth.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 8.80M | 93.00M | 159.40M | 214.30M | 70.90M |
| Net income | 4.50M | 69.20M | 128.90M | 181.20M | 35.70M |
| Selling general administrative | 0.10M | 1.20M | - | - | - |
| Gross profit | 511.70M | 502.90M | 618.10M | 578.80M | 470.50M |
| Reconciled depreciation | 72.50M | 72.30M | 54.20M | 36.90M | 29.50M |
| Ebit | 38.00M | 124.00M | 180.80M | 228.10M | 195.60M |
| Ebitda | 110.50M | 196.30M | 235.00M | 265.00M | 225.10M |
| Depreciation and amortization | 72.50M | 72.30M | 54.20M | 36.90M | 29.50M |
| Operating income | 56.10M | 126.40M | 180.80M | 228.10M | 112.50M |
| Other operating expenses | 731.50M | 750.70M | 809.50M | 682.20M | 583.80M |
| Interest expense | 29.20M | 32.20M | 17.50M | 13.80M | 38.70M |
| Tax provision | 4.30M | 23.80M | 30.50M | 33.10M | 35.20M |
| Interest income | 3.80M | 3.00M | 1.90M | - | - |
| Net interest income | -26.60M | -29.20M | -16.80M | -15.00M | -41.60M |
| Income tax expense | 4.30M | 23.80M | 30.50M | 33.10M | 35.20M |
| Total revenue | 787.60M | 877.10M | 1000.30M | 908.30M | 773.00M |
| Total operating expenses | 455.60M | 376.50M | 427.30M | 352.70M | 281.30M |
| Cost of revenue | 275.90M | 374.20M | 382.20M | 329.50M | 302.50M |
| Total other income expense net | -47.30M | -33.40M | -21.40M | -13.80M | -41.60M |
| Net income from continuing ops | 4.50M | 69.20M | 128.90M | 181.20M | 35.70M |
| Net income applicable to common shares | - | - | - | 181.20M | 34.70M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 889.80M | 952.40M | 992.60M | 859.10M | 652.80M |
| Intangible assets | 33.30M | 29.30M | 24.90M | 21.40M | 20.10M |
| Other current assets | 10.80M | 17.20M | - | 0.90M | 0.30M |
| Total liab | 523.40M | 584.20M | 588.40M | 530.90M | 502.10M |
| Total stockholder equity | 366.40M | 368.20M | 404.20M | 328.20M | 150.70M |
| Other current liab | 70.90M | 56.80M | 66.20M | 82.80M | 81.50M |
| Common stock | 9.60M | 9.60M | 10.00M | 10.00M | 10.00M |
| Capital stock | 9.60M | 9.60M | 10.00M | 10.00M | 10.00M |
| Retained earnings | 1749.10M | 1747.60M | 1782.20M | 1711.30M | 1538.10M |
| Other liab | - | - | - | 1.90M | 1.60M |
| Good will | 240.70M | 240.70M | 240.70M | 240.70M | 240.70M |
| Other assets | - | - | - | 9.60M | 7.40M |
| Cash | 155.90M | 111.10M | 157.50M | 228.00M | 113.60M |
| Total current liabilities | 158.60M | 153.50M | 164.50M | 155.00M | 152.30M |
| Current deferred revenue | - | 2.50M | - | - | - |
| Net debt | 248.20M | 365.90M | 294.30M | 165.80M | 252.80M |
| Short term debt | 48.30M | 55.40M | 34.10M | 19.80M | 18.20M |
| Short long term debt | 2.40M | 8.40M | 6.00M | - | - |
| Short long term debt total | 404.10M | 477.00M | 451.80M | 393.80M | 366.40M |
| Other stockholder equity | -1392.30M | -1389.00M | -1388.00M | -1393.10M | -1397.40M |
| Property plant equipment | - | - | - | 143.80M | 110.00M |
| Total current assets | 410.90M | 437.20M | 508.80M | 443.60M | 274.80M |
| Net tangible assets | - | - | - | 66.10M | -109.90M |
| Net receivables | 56.80M | 54.30M | 78.80M | 87.60M | 56.00M |
| Long term debt | 246.30M | 286.30M | 293.40M | 280.90M | 281.60M |
| Inventory | 187.40M | 254.60M | 257.80M | 123.00M | 101.50M |
| Accounts payable | 27.50M | 33.00M | 64.20M | 52.40M | 52.60M |
| Accumulated other comprehensive income | - | 11.00M | - | - | - |
| Non currrent assets other | 1.00M | 0.20M | 1.00M | - | - |
| Non current assets total | 478.90M | 515.20M | 483.80M | 415.50M | 378.00M |
| Capital lease obligations | 155.40M | 182.30M | 152.40M | 112.90M | 84.80M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -15.30M | -25.50M | -50.60M | -25.00M | -21.90M |
| Change to liabilities | - | - | 0.00M | -1.00M | 51.20M |
| Total cashflows from investing activities | -15.30M | -25.50M | - | -25.00M | -17.30M |
| Net borrowings | -33.00M | 0.00M | - | -24.00M | 183.50M |
| Total cash from financing activities | -134.20M | -185.90M | -99.50M | -47.00M | -44.00M |
| Net income | 4.50M | 69.20M | 128.90M | 181.20M | 74.80M |
| Change in cash | 44.80M | -46.40M | -70.50M | 114.40M | 58.80M |
| Begin period cash flow | 111.10M | 157.50M | 228.00M | 113.60M | 58.40M |
| End period cash flow | 155.90M | 111.10M | 157.50M | 228.00M | 117.20M |
| Total cash from operating activities | 196.30M | 167.90M | 77.30M | 184.40M | 121.40M |
| Issuance of capital stock | - | - | - | 0.00M | 37.80M |
| Depreciation | 72.50M | 72.30M | 54.20M | 36.90M | 29.50M |
| Other cashflows from investing activities | -6.90M | -7.30M | - | - | - |
| Dividends paid | 9.50M | 57.80M | 58.40M | 12.20M | 12.20M |
| Change to inventory | 62.70M | -1.60M | -133.20M | -18.30M | -36.10M |
| Change to account receivables | 6.30M | 23.00M | - | -23.30M | 0.80M |
| Sale purchase of stock | 0.00M | -50.50M | - | 0.00M | -35.00M |
| Other cashflows from financing activities | -91.70M | -34.00M | -41.10M | -34.80M | 83.70M |
| Change to netincome | - | - | 38.90M | 7.90M | 53.60M |
| Capital expenditures | 18.70M | 28.40M | 51.40M | 25.00M | 21.90M |
| Change in working capital | 84.30M | -16.30M | -145.90M | -42.60M | -17.00M |
| Stock based compensation | 7.20M | 4.00M | 0.50M | 5.20M | 11.50M |
| Other non cash items | 27.80M | 38.70M | 39.60M | 3.70M | 34.10M |
| Free cash flow | 177.60M | 139.50M | 25.90M | 159.40M | 99.50M |
Sector: Consumer Cyclical Industry: Footwear & Accessories
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DOCMF Dr. Martens plc |
- -% |
0.85 | 44.08 | 0.25 | 1.09 | 1.92 | 1.22 | 7.63 |
| NKE Nike Inc |
0.25 0.65% |
38.67 | 31.59 | 32.68 | 3.59 | 13.23 | 3.66 | 28.05 |
| ADDDF Adidas AG |
- -% |
187.00 | 18.41 | 11.59 | 1.12 | 4.23 | 1.13 | 8.94 |
| ADDYY Adidas AG ADR |
0.41 0.44% |
93.73 | 18.35 | 11.53 | 1.10 | 4.21 | 1.13 | 8.94 |
| ASCCY Asics Corp ADR |
1.22 4.15% |
30.62 | 33.36 | 29.24 | 0.03 | 12.03 | 4.01 | 19.16 |
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
28 Jamestown Road, London, United Kingdom, NW1 7BY
44 12 1415 7047
3700
| Name | Title | Year Born |
|---|---|---|
| Mr. Kenneth Wilson | CEO & Director | 1967 |
| Mr. Jon W. Mortimore | CFO & Director | NA |
| Mr. Geert Peeters | Chief Operating Officer | 1966 |
| Mr. Ronald Garricks | Chief Information Officer | NA |
| Ms. Emily Reichwald | Gen. Counsel & Company Sec. | NA |
| Ms. Meg Johnson | Chief Marketing Officer | NA |
| Ms. Sue Gannon | Chief HR Officer | NA |
| Mr. Lorenzo Moretti | Pres of EMEA | NA |
| Mr. Sean O'Neill | Chief Digital Officer | NA |
| Mr. Derek Chan | Pres of APAC | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...